drugset / Trial / NCT00695435

Tobramycin Tear Concentrations

NCT00695435

Phase 1 Completed 21 enrolled Alcon Research
RandomizedCrossoverQuadruple-blindTreatment

Summary

To evaluate the Tobramycin tear concentration values of TOBRADEX® Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension versus TOBREX® Ophthalmic Solution in normal volunteers.

Timeline

Start
2008-06
Primary completion
2008-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tobradex Unknown 0.05 %
Comparator Tobradex Unknown 0.3 %
Comparator Tobramycin Small molecule

Indications